What to watch with Pharmakogenetik Medicheck and skin aging?

Combining pharmacogenetic testing (e.g., Medicheck) with skin aging is currently not well supported by evidence. Pharmacogenetic tests primarily analyze variants in CYP enzymes (e.g., CYP1A2, CYP2D6) that affect drug metabolism. For skin aging, there are no established biomarkers or genes directly linked to the efficacy of anti‑aging ingredients (retinoids, antioxidants). Some studies suggest associations between certain gene variants (e.g., MC1R) and skin aging, but the evidence is mostly mechanistic or from GWAS. Moreover, many commercial tests lack clinical validation. Be cautious not to misinterpret results as medical diagnoses. A more holistic approach—focusing on lifestyle, UV protection, and diet—is advisable. The evidence for personalized skincare based on pharmacogenetics is currently weak.